IRBM to Disclose Strong Antitumor Efficacy of Novel Preclinical Agents Against Aggressive Brain Tumors and Acute Lymphoblastic Leukemia at AACR

IRBM S.p.A. United States of America France Germany Spain United Kingdom Italy California

View original content:https://www.prnewswire.co.uk/news-releases/irbm-to-disclose-strong-antitumor-efficacy-of-novel-preclinical-agents-against-aggressive-brain-tumors-and-acute-lymphoblastic-leukemia-at-aacr-302108379.html